Evome Medical Technologies Inc.
TSXV:EVMT 株式レポート
Evome Medical Technologies マネジメント 主要情報 CEO給与比率 33.2% CEO在任期間 1.4yrs CEOの所有権 n/a 経営陣の平均在職期間 less than a year 取締役会の平均在任期間 1.3yrs
経営陣の近況
Evome Medical Technologies Inc., Annual General Meeting, Nov 08, 2024 Oct 02
High number of new and inexperienced directors Jul 01
Evome Medical Technologies Inc. Announces Board Changes Feb 15 Evome Medical Technologies Inc. Announces Change of Principal Accounting Officer Feb 03
Salona Global Medical Device Corporation Announces Leslie Cross Retires from its Board of Directors Jan 18
Salona Global Medical Device Corporation Announces Resignation of Kyle L. Wilks as Board of Directors Jan 11
すべての更新を表示
Evome Medical Technologies Inc., Annual General Meeting, Nov 08, 2024 Oct 02
New major risk - Share price stability Aug 12
High number of new and inexperienced directors Jul 01 Riddell Sports Group, Inc. acquired Simbex, LLC from Evome Medical Technologies Inc. (TSXV:EVMT) for $3.6 million. Apr 03
Evome Medical Technologies Inc. announced delayed annual 10-K filing Apr 02
New major risk - Market cap size Mar 06
Evome Medical Technologies Inc. Announces Board Changes Feb 15 Evome Medical Technologies Inc. Announces Change of Principal Accounting Officer Feb 03
New major risk - Revenue and earnings growth Jan 30
Salona Global Medical Device Corporation Announces Leslie Cross Retires from its Board of Directors Jan 18
Salona Global Medical Device Corporation Announces Resignation of Kyle L. Wilks as Board of Directors Jan 11
Salona Global Medical Device Corporafion Announces the Debut of the Biodex Reac Five Step Trainer Dec 19
Salona Global Medical Device Corporation Showcases Biodex Products at Medica Trade Fair in Dusseldorf, Germany; Expanding Access to International Markets Nov 21
Salona Global Medical Device Corporation to Debut an Entire Next Generation Line of Products Nov 18
New major risk - Market cap size Nov 10
Salona Global Medical Device Corporation Announces Resignation of Dennis Nelson as Chief Accounting Officer and Treasurer Oct 26 Salona Global Medical Device Corporation to Report Q3, 2023 Results on Nov 14, 2023
New major risk - Financial position Aug 16
Salona Global Medical Device Corporation Appoints Mike Seckler as Permanent CEO Jul 26
Salona Global Medical Device Corporation, Annual General Meeting, Aug 11, 2023 Jun 27
Salona Global Appoints Michael Seckler, as Interim CEO Jun 15
Salona Global Announces Appointment of Lana Newishy to Its Board of Directors as Executive Vice Chair May 26
Salona Global Medical Device Corporation (TSXV:SGMD) acquired Arrowhead Medical, LLC for $0.85 million. May 17
Salona Global Medical Device Corporation to Report Q1, 2023 Results on May 16, 2023 May 12
Price target decreased by 10.0% to CA$2.25 Feb 14
Salona Global Medical Device Corporation to Report Q3, 2023 Results on Jan 17, 2023 Jan 13
Salona Global Medical Device Corporation (TSXV:SGMD) entered into a binding agreement to acquire Physical medicine assets from Biodex Medical Systems, Inc for $8 million. Nov 30
High number of new and inexperienced directors Nov 16
High number of new and inexperienced directors Nov 01
High number of new and inexperienced directors Oct 04
Salona Global Medical Device Corporation Appoints Jane Kiernan as Director Sep 30
Salona Global Medical Device Corporation Appoints Dennis Nelson as CFO Aug 23
Salona Global Medical Device Corporation Announces Chief Executive Officer Changes Jul 16
Salona Global Medical Device Corporation Appoints Luke Faulstick as CEO Jul 15
Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Jun 02
Salona Global Medical Device Corporation to Report Fiscal Year 2022 Results on May 31, 2022 Jun 02
Forecast to breakeven in 2023 May 04
High number of new and inexperienced directors Apr 27
Salona Global Medical Device Corporation Announces Expansion of Mio-Guard Product Lines Apr 27
Salona Global Medical Device Corporation (TSXV:SGMD) executed a binding definitive agreement to acquire Mio-Guard LLC from Ken Zisholz for $1.7 million. Feb 24 Salona Global Medical Device Corporation announced that it has received CAD 4.26195 million in funding Feb 17
Salona Global Medical Device Corporation announced that it expects to receive CAD 4.004 million in funding Jan 28
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Jan 16
Salona Global Medical Device Corporation Provides Earnings Guidance for the Fiscal Year End February 28, 2022 Dec 11
Second quarter 2022 earnings released: CA$0.024 loss per share (vs CA$0.008 loss in 2Q 2021) Oct 17
Here's Why We're Not Too Worried About Salona Global Medical Device's (CVE:SGMD) Cash Burn Situation Jun 11
CEO報酬分析 Evome Medical Technologies の収益と比較して、Mike Seckler の報酬はどのように変化したか？ 日付 総報酬 給与 会社業績 Jun 30 2024 n/a n/a -CA$19m
Mar 31 2024 n/a n/a -CA$18m
Dec 31 2023 CA$409k CA$136k -CA$16m
報酬と市場: Mikeの 総報酬 ($USD 293.76K ) は、 Canadian市場 ($USD 172.36K ) の同規模の企業の平均を上回っています。
報酬と収益: Mikeの報酬と会社の業績を比較するにはデータが不十分です。
CEO（最高経営責任者 Mr. Michael Seckler, also known as Mike, served as an Interim Chief Executive Officer at Evome Medical Technologies Inc. (formerly known as Salona Global Medical Device Corporation) since June 13, 2023 unt ... Show more
リーダーシップ・チーム 名称 ポジション 在職期間 報酬 所有権 CEO & Executive Director 1.4yrs CA$409.04k データなし Principal Accounting Officer & Interim Chief Financial Officer less than a year データなし データなし Vice President of Marketing & Sales 1.1yrs データなし データなし Director of Human Resources less than a year データなし データなし Vice President of Capital Markets & Financial Communications no data データなし データなし Executive Officer no data データなし データなし
もっと見る
経験豊富な経営陣: EVMTの経営陣は 経験豊富 とはみなされません ( 1年の平均在職年数)。これは新しいチームを示唆しています。
取締役 名称 ポジション 在職期間 報酬 所有権 CEO & Executive Director 1.3yrs CA$409.04k データなし Independent Chairman 4.2yrs CA$40.49k 0.057% CA$ 5.7k Independent Director less than a year データなし データなし Independent Director less than a year データなし データなし Non-Executive Vice Chair 1.5yrs CA$282.79k 0% CA$ 0
もっと見る
経験豊富なボード: EVMTの 取締役会 は 経験豊富 ではない ( 1.3年の平均在任期間) ため、新しい取締役会が必要であると考えられます。
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
